The post Arthur Hayes Gives Major USDT Warning Tied to Bitcoin and Gold appeared on BitcoinEthereumNews.com. BitMEX co-founder Arthur Hayes has warned that Tether risks balance-sheet insolvency if its Bitcoin and gold reserves suffer a 30% drawdown. His November 30 post targets the structural vulnerabilities in Tether’s latest asset allocation. He suggests the firm has tied its solvency to the performance of volatile risk assets rather than relying solely on the stability of government debt. Sponsored Hayes Critique Tether’s Gold and Stablecoin Holdings Hayes’ assessment draws on Tether’s third-quarter 2025 attestation, which reveals a significant rotation into non-fiat collateral. The report shows the issuer now holds $12.9 billion in precious metals and $9.9 billion in Bitcoin. According to Hayes, this allocation represents a deliberate “interest rate trade.” His thesis posits that Tether is preparing for Federal Reserve rate cuts that would compress the yield on its massive portfolio of US Treasury bills. “[Tether] thinks the Fed will cut rates, which crushes their interest income. In response, they are buying gold and BTC that should in theory moon as the price of money falls,” Hayes noted. However, Hayes argues this strategy introduces asymmetric risk to the company’s thin layer of equity. Hayes contends that this figure exceeds Tether’s surplus capital, rendering the firm theoretically insolvent even if it remains operationally liquid. Sponsored He warned that such a scenario would likely force large holders and exchanges to demand a real-time view of the balance sheet to assess the safety of the peg. Notably, this warning aligns with S&P Global’s decision to assign USDT a ‘5’ rating, the lowest on its scale. Industry Stakeholders Defend Tether Industry proponents maintain that the insolvency thesis conflates balance sheet accounting with actual liquidity risk. Tran Hung, CEO of UQUID Card, dismissed the warning as fundamentally flawed. He noted that the vast majority of Tether’s $181.2 billion balance sheet remains parked in highly… The post Arthur Hayes Gives Major USDT Warning Tied to Bitcoin and Gold appeared on BitcoinEthereumNews.com. BitMEX co-founder Arthur Hayes has warned that Tether risks balance-sheet insolvency if its Bitcoin and gold reserves suffer a 30% drawdown. His November 30 post targets the structural vulnerabilities in Tether’s latest asset allocation. He suggests the firm has tied its solvency to the performance of volatile risk assets rather than relying solely on the stability of government debt. Sponsored Hayes Critique Tether’s Gold and Stablecoin Holdings Hayes’ assessment draws on Tether’s third-quarter 2025 attestation, which reveals a significant rotation into non-fiat collateral. The report shows the issuer now holds $12.9 billion in precious metals and $9.9 billion in Bitcoin. According to Hayes, this allocation represents a deliberate “interest rate trade.” His thesis posits that Tether is preparing for Federal Reserve rate cuts that would compress the yield on its massive portfolio of US Treasury bills. “[Tether] thinks the Fed will cut rates, which crushes their interest income. In response, they are buying gold and BTC that should in theory moon as the price of money falls,” Hayes noted. However, Hayes argues this strategy introduces asymmetric risk to the company’s thin layer of equity. Hayes contends that this figure exceeds Tether’s surplus capital, rendering the firm theoretically insolvent even if it remains operationally liquid. Sponsored He warned that such a scenario would likely force large holders and exchanges to demand a real-time view of the balance sheet to assess the safety of the peg. Notably, this warning aligns with S&P Global’s decision to assign USDT a ‘5’ rating, the lowest on its scale. Industry Stakeholders Defend Tether Industry proponents maintain that the insolvency thesis conflates balance sheet accounting with actual liquidity risk. Tran Hung, CEO of UQUID Card, dismissed the warning as fundamentally flawed. He noted that the vast majority of Tether’s $181.2 billion balance sheet remains parked in highly…

Arthur Hayes Gives Major USDT Warning Tied to Bitcoin and Gold

BitMEX co-founder Arthur Hayes has warned that Tether risks balance-sheet insolvency if its Bitcoin and gold reserves suffer a 30% drawdown.

His November 30 post targets the structural vulnerabilities in Tether’s latest asset allocation. He suggests the firm has tied its solvency to the performance of volatile risk assets rather than relying solely on the stability of government debt.

Sponsored

Hayes Critique Tether’s Gold and Stablecoin Holdings

Hayes’ assessment draws on Tether’s third-quarter 2025 attestation, which reveals a significant rotation into non-fiat collateral. The report shows the issuer now holds $12.9 billion in precious metals and $9.9 billion in Bitcoin.

According to Hayes, this allocation represents a deliberate “interest rate trade.” His thesis posits that Tether is preparing for Federal Reserve rate cuts that would compress the yield on its massive portfolio of US Treasury bills.

However, Hayes argues this strategy introduces asymmetric risk to the company’s thin layer of equity.

Hayes contends that this figure exceeds Tether’s surplus capital, rendering the firm theoretically insolvent even if it remains operationally liquid.

Sponsored

He warned that such a scenario would likely force large holders and exchanges to demand a real-time view of the balance sheet to assess the safety of the peg. Notably, this warning aligns with S&P Global’s decision to assign USDT a ‘5’ rating, the lowest on its scale.

Industry Stakeholders Defend Tether

Industry proponents maintain that the insolvency thesis conflates balance sheet accounting with actual liquidity risk.

Tran Hung, CEO of UQUID Card, dismissed the warning as fundamentally flawed.

He noted that the vast majority of Tether’s $181.2 billion balance sheet remains parked in highly liquid, low-risk instruments. Indeed, the attestation confirms Tether holds $112.4 billion in US Treasury Bills and nearly $21 billion in repo agreements.

Sponsored

Tether USDT Stablecoin Reserves. Source: Tether

Hung argues these “Cash and Cash Equivalents” provide a liquidity wall sufficient to cover the overwhelming majority of USDT in circulation.

Considering this, he argued that Tether would remain fully redeemable even if a market downturn eliminated its corporate equity buffer.

Sponsored

Meanwhile, Cory Klippsten, CEO of Swan Bitcoin, pointed out that Tether’s leverage is more aggressive than that of traditional financial institutions.

According to him, a 4% portfolio loss would erase the common equity, while A 16% drop in the riskiest assets would have the same effect.

However, despite the structural leverage, he suggests the risk is mitigated by Tether’s sheer profitability. Indeed, the stablecoin issuer is on track to record a profit of more than $15 billion this year.

Moreover, Klippsten also noted that Tether’s owners recently withdrew a $12 billion dividend. Considering this, he argued they have the capacity to recapitalize the firm immediately if its buffer were ever breached.

Source: https://beincrypto.com/arthur-hayes-tether-usdt-warning-gold-bitcoin/

Market Opportunity
Major Logo
Major Price(MAJOR)
$0.13418
$0.13418$0.13418
+3.87%
USD
Major (MAJOR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26